FDA video warning on metoclopramide and tardive dyskinesia
Video: patient safety warning on chronic use of metoclopramide and the risk of developing tardive dyskinesia.
Lectures on antiemetics pharmacology: MOA, indications, side effects and new drugs reviewed
PowerPoint slideshows on pharmacology of antiemetics .MOA, dosing, indications and side effects of: serotonin and dopamine antagonists, anticholinergics, new antiemetics.
Metoclopramide and tardive dyskinesia: FDA adds boxed warning
The FDA issued a press release (dated February 26, 2009) in which they announce that the agency will require Metoclopramide (Maxolon, Reglan, Degan, Maxeran, Primperan, and Pylomid) manufacturers to include a boxed warning about the risk of long term or high dose use: The U.S. Food and Drug Administration announced today that manufacturers of metoclopramide, […]